GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Net Margin %

Peptron (XKRX:087010) Net Margin % : -844.53% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Peptron Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Peptron's Net Income for the three months ended in Mar. 2024 was ₩-4,031 Mil. Peptron's Revenue for the three months ended in Mar. 2024 was ₩477 Mil. Therefore, Peptron's net margin for the quarter that ended in Mar. 2024 was -844.53%.

The historical rank and industry rank for Peptron's Net Margin % or its related term are showing as below:

XKRX:087010' s Net Margin % Range Over the Past 10 Years
Min: -983.7   Med: -182.38   Max: -96.48
Current: -600.24


XKRX:087010's Net Margin % is ranked worse than
67.38% of 1024 companies
in the Biotechnology industry
Industry Median: -148.36 vs XKRX:087010: -600.24

Peptron Net Margin % Historical Data

The historical data trend for Peptron's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Net Margin % Chart

Peptron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -983.70 -589.03 -227.07 -259.08 -476.43

Peptron Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -344.82 -648.32 -605.78 -407.90 -844.53

Competitive Comparison of Peptron's Net Margin %

For the Biotechnology subindustry, Peptron's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peptron's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Peptron's Net Margin % distribution charts can be found below:

* The bar in red indicates where Peptron's Net Margin % falls into.



Peptron Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Peptron's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15921.882/3341.894
=-476.43 %

Peptron's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-4030.646/477.267
=-844.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peptron  (XKRX:087010) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Peptron Net Margin % Related Terms

Thank you for viewing the detailed overview of Peptron's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Peptron (XKRX:087010) Business Description

Traded in Other Exchanges
N/A
Address
37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines